Beta Bionics, Common Stock Alpha and Beta Analysis
| BBNX Stock | 31.97 0.70 2.24% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Beta Bionics, Common. It also helps investors analyze the systematic and unsystematic risks associated with investing in Beta Bionics, over a specified time horizon. Remember, high Beta Bionics,'s alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Beta Bionics,'s market risk premium analysis include:
Beta 2.18 | Alpha 0.44 | Risk 4.09 | Sharpe Ratio 0.2 | Expected Return 0.81 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Beta Bionics, Backtesting, Beta Bionics, Valuation, Beta Bionics, Correlation, Beta Bionics, Hype Analysis, Beta Bionics, Volatility, Beta Bionics, History and analyze Beta Bionics, Performance. Beta Bionics, Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Beta Bionics, market risk premium is the additional return an investor will receive from holding Beta Bionics, long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Beta Bionics,. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Beta Bionics,'s performance over market.| α | 0.44 | β | 2.18 |
Beta Bionics, expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Beta Bionics,'s Buy-and-hold return. Our buy-and-hold chart shows how Beta Bionics, performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Beta Bionics, Market Price Analysis
Market price analysis indicators help investors to evaluate how Beta Bionics, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Beta Bionics, shares will generate the highest return on investment. By understating and applying Beta Bionics, stock market price indicators, traders can identify Beta Bionics, position entry and exit signals to maximize returns.
Beta Bionics, Return and Market Media
The median price of Beta Bionics, for the period between Wed, Oct 1, 2025 and Tue, Dec 30, 2025 is 27.22 with a coefficient of variation of 15.42. The daily time series for the period is distributed with a sample standard deviation of 4.04, arithmetic mean of 26.18, and mean deviation of 3.57. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 1154 shares by Stephen Feider of Beta Bionics, at 22.2778 subject to Rule 16b-3 | 10/03/2025 |
2 | Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | 10/28/2025 |
3 | Beta Bionics raises 2025 revenue guidance to 96.5M and projects Q4 gross margin improvement amid pharmacy channel expansion | 10/29/2025 |
4 | Beta Bionics, Inc. Q3 2025 Earnings Call Transcript | 10/30/2025 |
5 | Disposition of 119 shares by Palasis Maria of Beta Bionics, at 27.4502 subject to Rule 16b-3 | 10/31/2025 |
6 | Head to Head Contrast Inogen Beta Bionics | 11/05/2025 |
7 | The Insider Report The Bears Have Been Poked Will They Fall Back Asleep | 11/10/2025 |
8 | Disposition of 656 shares by Hopman Mark of Beta Bionics, at 5.1 subject to Rule 16b-3 | 11/19/2025 |
9 | Disposition of 500 shares by Palasis Maria of Beta Bionics, at 29.964 subject to Rule 16b-3 | 12/01/2025 |
10 | Disposition of 3278 shares by Saint Sean of Beta Bionics, at 29.3359 subject to Rule 16b-3 | 12/02/2025 |
11 | Beta Bionics Trading Up 7 percent Heres What Happened | 12/03/2025 |
12 | Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026 | 12/08/2025 |
13 | Why Beta Bionics Inc. stock is a value investor pick - Weekly Stock Recap Safe Entry Zone Identification - ulpravda.ru | 12/19/2025 |
About Beta Bionics, Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Beta or other stocks. Alpha measures the amount that position in Beta Bionics, Common has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2024 | 2025 (projected) | Days Sales Outstanding | 135.35 | 67.23 | 111.42 | PTB Ratio | 9.08 | 1.98 | 1.88 |
Beta Bionics, Investors Sentiment
The influence of Beta Bionics,'s investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Beta. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Beta Bionics,'s public news can be used to forecast risks associated with an investment in Beta. The trend in average sentiment can be used to explain how an investor holding Beta can time the market purely based on public headlines and social activities around Beta Bionics, Common. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Beta Bionics,'s market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Beta Bionics,'s and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Beta Bionics,'s news discussions. The higher the estimated score, the more favorable is the investor's outlook on Beta Bionics,.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Beta Bionics, in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Beta Bionics,'s short interest history, or implied volatility extrapolated from Beta Bionics, options trading.
Build Portfolio with Beta Bionics,
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Beta Stock Analysis
When running Beta Bionics,'s price analysis, check to measure Beta Bionics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beta Bionics, is operating at the current time. Most of Beta Bionics,'s value examination focuses on studying past and present price action to predict the probability of Beta Bionics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beta Bionics,'s price. Additionally, you may evaluate how the addition of Beta Bionics, to your portfolios can decrease your overall portfolio volatility.